[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100630349":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":7,"centralContacts":8,"locations":14,"responsibleParty":33,"collaborators":7,"id":37,"slug":7,"hasResults":38,"nctId":39,"briefTitle":40,"officialTitle":40,"acronym":41,"eligibilityCriteria":42,"healthyVolunteers":43,"sex":44,"minAge":45,"maxAge":7,"enrollmentInfo":46,"targetDuration":7,"studyType":49,"phases":7,"briefSummary":50,"conditions":51,"keywords":7,"overallStatus":54,"whyStopped":7,"lastUpdateSubmitDate":55,"lastUpdatePostDateStruct":56,"startDateStruct":59,"completionDateStruct":61,"leadSponsor":63,"locationsCount":64},{"fullName":5,"class":6},"Asian Institute of Gastroenterology, India","OTHER",null,[9],{"name":10,"role":11,"phone":12,"phoneExt":7,"email":13},"Dr.Hardik Rughwani Dr.Hardik Rughwani, MBBS, MD, DM","CONTACT","+91-9426928600","hardik.hr@gmail.com",[15],{"facility":16,"status":7,"city":17,"state":18,"zip":19,"country":20,"countryCode":21,"cosmosGeoPoint":22,"geoPoint":27,"contacts":28},"AIG Hospitals","Hyderabad","Telangana","500032","India","IN",{"type":23,"coordinates":24},"Point",[25,26],78.45636,17.38405,{"lat":26,"lon":25},[29],{"name":30,"role":11,"phone":31,"phoneExt":7,"email":32},"Sana Fathima Facility Contact","9182859523","aigresearch7@gmail.com",{"type":34,"investigatorFullName":35,"investigatorTitle":36,"investigatorAffiliation":5,"oldNameTitle":7,"oldOrganization":7},"PRINCIPAL_INVESTIGATOR","Mohan Ramchandani","Director, Department of Interventional Endoscopy","100630349",false,"NCT07486518","A Multicentre Observational Cross-Sectional Study of The Gastric Precancerous Epithelial Pathway Using High-Definition Endoscopy And Histopathology In India","IND-PREP","1. Adults aged ≥40 years undergoing upper gastrointestinal endoscopy for dyspepsia or other clinical indications (nonalarming and alarming symptoms both).\n2. Ability to provide written informed consent.\n\nExclusion Criteria:\n\n1. Known gastric malignancy.\n2. Prior gastric surgery (excluding H. pylori eradication).\n3. Contraindications to endoscopy or biopsy.\n4. Known hereditary gastric cancer syndromes.",true,"ALL","40 Years",{"count":47,"type":48},4000,"ESTIMATED","OBSERVATIONAL","To estimate the prevalence of histologically confirmed early gastric cancer (EGC) in an Indian multicentre cohort undergoing standardised high-quality upper gastrointestinal endoscopy. EGC is defined as gastric adenocarcinoma confined to the mucosa or submucosa (T1), irrespective of lymph node status, based on histopathology.",[52,53],"Gastric Adenocarcinoma","Early Gastric Cancer","NOT_YET_RECRUITING","2026-06-02",{"date":57,"type":58},"2026-06-04","ACTUAL",{"date":60,"type":48},"2026-07-01",{"date":62,"type":48},"2028-07-01",{"name":5,"class":6},1]